Jean Frederic Viret Coherus Bio Sciences, Inc. (CHRS) insider trading activity

Jean Frederic Viret is Chief Financial Officer of Coherus BioSciences, Inc.. Currently has a direct ownership of 61,295 shares of CHRS, which is worth approximately $49,036. The most recent transaction as insider was on Feb 01, 2021, when has been sold 7,402 shares (Common Stock) at a price of $21.55 per share, resulting in proceeds of $159,513. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.3K

0% 3M change

0% 12M change

Total Value Held $49,036

Jean-Frederic Viret Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2021	SELL Open market or private sale	$159,513 $21.55 p/Share	7,402 Reduced 10.77%	61,295 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$74,390 $10.05 p/Share	7,402 Added 9.73%	68,697 Common Stock
Jan 25 2021	SELL Open market or private sale	$902,115 $19.55 p/Share	46,144 Reduced 42.95%	61,295 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$402,000 $10.05 p/Share	40,000 Added 27.13%	107,439 Common Stock
Jan 11 2021	BUY Grant, award, or other acquisition	-	31,250 Added 31.67%	67,439 Common Stock
Jan 10 2021	SELL Payment of exercise price or tax liability	$74,174 $18.18 p/Share	4,080 Reduced 10.13%	36,189 Common Stock
Nov 17 2020	SELL Open market or private sale	$34,893 $17.49 p/Share	1,995 Reduced 4.89%	38,769 Common Stock, $0.0001 ...
Nov 17 2020	BUY Exercise of conversion of derivative security	$20,250 $13.5 p/Share	1,500 Added 3.59%	40,269 Common Stock, $0.0001 ...
Oct 14 2020	SELL Open market or private sale	$116,736 $19.0 p/Share	6,144 Reduced 13.19%	40,423 Common Stock, $0.0001 ...

Also insider at

NGM

NGM BIOPHARMACEUTICALS INC Healthcare

Chief Financial Officer